Catalyst Wire Dossier Catalyst Wire Dossier

MEM 1003

· Memory Pharmaceuticals
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MEM 1003, covering 2008-05-06 to 2008-05-06. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of MEM 1003 Versus Placebo for the Treatment of Patients With Bipolar I Disorder [Phase 2]

See pricing